Aloxi Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting
Condition:   Nausea With Vomiting Chemotherapy-Induced Interventions:   Drug: Palonosetron Hydrochloride Buccal Film 0.25 Mg;   Drug: Palonosetron Hydrochloride Buccal Film 0.5 Mg;   Drug: Palonosetron Hydrochloride, 0.25 Mg/5 mL Intravenous Solution Sponsor:   Xiamen LP Pharmaceutical Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2020 Category: Research Source Type: clinical trials